Latest 8-K filings

Western Digital Corporation announced the redemption of its 3.00% Convertible Senior Notes due 2028, with a redemption date set for November 16, 2026.

Perdoceo Education Corporation announced a definitive agreement to acquire South University Savannah, LLC, for an initial cash payment of $150 million, plus potential deferred and earn-out payments, aiming to expand its health sciences offerings.

Strive, Inc. announced the purchase of 469 bitcoin and provided an update on its cash, digital asset, and stock holdings as of September 11, 2026.

AirJoule Technologies Corporation announced its acquisition of BitSink LLC, a U.S.-based designer and manufacturer of cooling, power distribution, and racking infrastructure for AI and high-density data centers.

KeyCorp presented updated financial performance and outlook at the Barclays Global Financial Services Conference, revising key growth targets upwards.

National Healthcare Properties, Inc. announced the resignation of director Edward M. Weil, Jr. effective September 11, 2026.

Texas Capital Bancshares, Inc. announced its intention to voluntarily delist from Nasdaq and transfer its common and preferred stock listings to the Texas Stock Exchange LLC (TXSE), effective October 8, 2026.

PBF Energy's subsidiary, PBF Holding, announced a $500 million senior unsecured exchangeable notes offering due 2032 to refinance existing 2030 notes, alongside an asset acquisition of hydrogen plants.

VisionWave Holdings has been prequalified by Liberia's petroleum authority to negotiate a Production Sharing Contract, marking a potential entry into the upstream oil sector.

Soluna Holdings announced its 100 MW Project Dorothy campus has conditionally achieved Base Load classification in ERCOT's Batch Zero process, a significant step for renewable energy data center development.

Cullinan Therapeutics announced positive Phase 3 results for zipalertinib plus chemotherapy, demonstrating a significant improvement in progression-free survival for NSCLC patients with EGFR exon 20 insertion mutations.

NPK International Inc. announced the appointment of James JJ Barton as Executive Vice President, Commercial Growth & Operations, effective September 22, 2026, succeeding Lori Briggs.

Solid Power, Inc. published an investor presentation detailing advancements in its solid-state battery technology, strategic partnerships, and a phased approach towards commercial-scale production.

Q32 Bio Inc. announced the appointment of Jos Trevejo, M.D., Ph.D., as Chief Medical Officer and Ellie Hershberger, Pharm.D., as Chief Development Officer to bolster its clinical-stage operations.

FrontView REIT, Inc. released an investor update on September 14, 2026, detailing strong YTD investment activity, improved per-share growth metrics, and a robust capital structure.

Immunocore Holdings plc announced the achievement of target patient enrollment in its Phase 3 TEBE-AM clinical trial for advanced melanoma.

Armata Pharmaceuticals announced its Staphylococcus aureus therapeutic candidate, AP-SA02, has received U.S. FDA Breakthrough Therapy designation, potentially accelerating its path to market.

Corbus Pharmaceuticals announced positive topline data from its CANYON-1 Phase 1b trial of CRB-913 for obesity, showing significant weight loss and a favorable safety profile.

Bally's Corporation announced it has secured $560 million in new financing to support the development of its Bronx project and for general corporate purposes.

Flowserve Corporation announced the appointment of Brian Ezzell as Senior Vice President and Chief Financial Officer, succeeding Amy B. Schwetz, with no expected change to the company's full-year guidance.

Hain Celestial Group announced a definitive agreement to sell its international business to Aurelius for approximately $323 million, aiming to simplify its portfolio and reduce debt.

Brookfield Corporation and Brookfield Asset Management announced their upcoming 2026 Investor Day events, scheduled for September 17, 2026, in New York.

American Healthcare REIT, Inc. has issued a Form 8-K to disclose a presentation intended for investor meetings, available on their website.

State Street Corporation has announced two key executive leadership appointments, effective immediately, to bolster its strategic operations.

Addentax Group Corp. has entered into private placement agreements to issue approximately $2.5 million in common stock to an investor for general corporate purposes.

Perspective Therapeutics and Merck have entered a clinical collaboration to evaluate Perspective's [212Pb]PSV359 in combination with Merck's Keytruda for FAP-positive solid tumors.

Lipocine Inc. has announced the commencement of its Phase 3 BLOOM study for LPCN 1154, an oral treatment for postpartum depression, with first patient dosing expected in early Q4 2026.

Embrace Change Acquisition Corp. announced the termination of its merger agreement with Tianji Tire Global (Cayman) Limited.

WhiteFiber, Inc. announces substantial new cloud service contracts totaling over $550 million and expansion into new data center sites, signaling strong demand for its AI infrastructure solutions.

Oracle Corporation announced that Executive Chair Larry Ellison has canceled his 10b5-1 plan to sell company stock, with no shares sold prior to termination.